Bioequivalency test for 105 products completed.

Published: 1999-07-27 14:36:00

Updated: 1999-07-27 14:36:00

The KFDA reported that as of the end of July this year 105 drugs have completed the bioequivalency test since implementation of its provision in 1998, which was 90 items increases during the past 9 months from 85 products reported in the National Audit held in Oct last year, showing a sharp inte...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK